Directory → Gematotropona funds → Coagulants (including factors such as blood clotting), gemostatiki → Koeit-dwi
This page is translated automatically with a help of Google Translate
Koeit-dwiSee also PhytomenadioneRoman nameKoate-DVIThe composition and the form ofPowder liofilizirovanny for solution for intravenous-1 fl.antigemofilny factor VIII plazmaticeski, IU-200-300vo meals together with the solvent in vials to 5 ml, needles and the system for the introduction; in the paper cartons 1 Complekt.poroshok liofilizirovanny for solution for intravenous-1 fl.antigemofilny factor VIII plazmaticeski, IU-400-600vo meals together with the solvent in vials to 5 ml, needles and the system for the introduction; in the paper cartons 1 Complekt.poroshok liofilizirovanny for solution for intravenous-1 fl.antigemofilny factor VIII plazmaticeski, IU-800-1300vo meals together with the solvent in vials of 10 ml, needles and the system for the introduction; in the paper cartons 21.90.PharmacokineticsData for farmakokinetike Koeit-dwi drug is not available.Indicationsthe treatment and prevention of bleeding in hemophilia A, including in the emergency planning and surgical interventions.ContraindicationsHypersensitivity to the drug.Patient interactionPrescribed drug interaction Koeit-dwi not described.OverdosingSymptoms of drug overdose Koeit-dwi not known.Storage conditionsList B. In the dark place at a temperature of 2-8 ° C (not freezing)Shelf life24 mon. After cooking solution to three hoursThe registration012353/01-2000The drug formsSterilized, stable, clean, dry cells antigemofilland human factor. |
All products of this group |